Show simple item record

Epigenetic regulation of IL‐12‐dependent T cell proliferation

dc.contributor.authorSchaller, Matthew
dc.contributor.authorIto, Toshihiro
dc.contributor.authorAllen, Ronald M.
dc.contributor.authorKroetz, Danielle
dc.contributor.authorKittan, Nicolai
dc.contributor.authorPtaschinski, Catherine
dc.contributor.authorCavassani, Karen
dc.contributor.authorCarson, William F.
dc.contributor.authorGodessart, Nuria
dc.contributor.authorGrembecka, Jolanta
dc.contributor.authorCierpicki, Tomasz
dc.contributor.authorDou, Yali
dc.contributor.authorKunkel, Steven L.
dc.date.accessioned2018-02-05T16:33:05Z
dc.date.available2018-02-05T16:33:05Z
dc.date.issued2015-10
dc.identifier.citationSchaller, Matthew; Ito, Toshihiro; Allen, Ronald M.; Kroetz, Danielle; Kittan, Nicolai; Ptaschinski, Catherine; Cavassani, Karen; Carson, William F.; Godessart, Nuria; Grembecka, Jolanta; Cierpicki, Tomasz; Dou, Yali; Kunkel, Steven L. (2015). "Epigenetic regulation of IL‐12‐dependent T cell proliferation." Journal of Leukocyte Biology 98(4): 601-613.
dc.identifier.issn0741-5400
dc.identifier.issn1938-3673
dc.identifier.urihttps://hdl.handle.net/2027.42/141412
dc.publisherWiley Periodicals, Inc.
dc.subject.othertrithorax
dc.subject.otherTh1 differentiation
dc.subject.otherhistone methylation
dc.subject.otherSTAT4
dc.titleEpigenetic regulation of IL‐12‐dependent T cell proliferation
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMicrobiology and Immunology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.contributor.affiliationumDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA;
dc.contributor.affiliationotherDermatology Research, Almirall, S.A., St Feliu de Llobregat, Spain
dc.contributor.affiliationotherDepartment of Immunology, Nara Medical University, Nara, Japan; and, Spain
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/141412/1/jlb0601-sup-0001.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/141412/2/jlb0601.pdf
dc.identifier.doi10.1189/jlb.1A0814-375RR
dc.identifier.sourceJournal of Leukocyte Biology
dc.identifier.citedreferenceKaplan, M.H., Sun, Y.L., Hoey, T., Grusby, M.J. ( 1996 ) Impaired IL‐12 responses and enhanced development of Th2 cells in Stat4‐deficient mice. Nature 382, 174 – 177.
dc.identifier.citedreferenceYamashita, M., Hirahara, K., Shinnakasu, R., Hosokawa, H., Norikane, S., Kimura, M.Y., Hasegawa, A., Nakayama, T. ( 2006 ) Crucial role of MLL for the maintenance of memory T helper type 2 cell responses. Immunity 24, 611 – 622.
dc.identifier.citedreferenceOnodera, A., Yamashita, M., Endo, Y., Kuwahara, M., Tofukuji, S., Hosokawa, H., Kanai, A., Suzuki, Y., Nakayama, T. ( 2010 ) STAT6‐mediated displacement of polycomb by trithorax complex establishes long‐term maintenance of GATA3 expression in T helper type 2 cells. J. Exp. Med. 207, 2493 – 2506.
dc.identifier.citedreferenceLim, D.A., Huang, Y.C., Swigut, T., Mirick, A.L., Garcia‐Verdugo, J.M., Wysocka, J., Ernst, P., Alvarez‐Buylla, A. ( 2009 ) Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells. Nature 458, 529 – 533.
dc.identifier.citedreferenceLiu, H., Cheng, E.H., Hsieh, J.J. ( 2007 ) Bimodal degradation of MLL by SCFSkp2 and APCCdc20 assures cell cycle execution: a critical regulatory circuit lost in leukemogenic MLL fusions. Genes Dev. 21, 2385 – 2398.
dc.identifier.citedreferenceMuntean, A.G., Hess, J.L. ( 2012 ) The pathogenesis of mixed‐lineage leukemia. Annu. Rev. Pathol. 7, 283 – 301.
dc.identifier.citedreferenceBird, J.J., Brown, D.R., Mullen, A.C., Moskowitz, N.H., Mahowald, M.A., Sider, J.R., Gajewski, T.F., Wang, C.R., Reiner, S.L. ( 1998 ) Helper T cell differentiation is controlled by the cell cycle. Immunity 9, 229 – 237.
dc.identifier.citedreferenceKaech, S.M., Ahmed, R. ( 2001 ) Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells. Nat. Immunol. 2, 415 – 422.
dc.identifier.citedreferenceWeng, A.P., Aster, J.C. ( 2003 ) No T without D3: a critical role for cyclin D3 in normal and malignant precursor T cells. Cancer Cell 4, 417 – 418.
dc.identifier.citedreferenceNakayama, T., Yamashita, M. ( 2009 ) Critical role of the Polycomb and Trithorax complexes in the maintenance of CD4 T cell memory. Semin. Immunol. 21, 78 – 83.
dc.identifier.citedreferenceShi, A., Murai, M.J., He, S., Lund, G., Hartley, T., Purohit, T., Reddy, G., Chruszcz, M., Grembecka, J., Cierpicki, T. ( 2012 ) Structural insights into inhibition of the bivalent menin‐MLL interaction by small molecules in leukemia. Blood 120, 4461 – 4469.
dc.identifier.citedreferenceChensue, S.W., Warmington, K., Ruth, J., Lincoln, P., Kuo, M.C., Kunkel, S.L. ( 1994 ) Cytokine responses during mycobacterial and schistosomal antigen‐induced pulmonary granuloma formation. Production of Th1 and Th2 cytokines and relative contribution of tumor necrosis factor. Am. J. Pathol. 145, 1105 – 1113.
dc.identifier.citedreferenceHeinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y.C., Laslo, P., Cheng, J.X., Murre, C., Singh, H., Glass, C.K. ( 2010 ) Simple combinations of lineage‐determining transcription factors prime cis‐regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576 – 589.
dc.identifier.citedreferenceAfkarian, M., Sedy, J.R., Yang, J., Jacobson, N.G., Cereb, N., Yang, S.Y., Murphy, T.L., Murphy, K.M. ( 2002 ) T‐bet is a STAT1‐induced regulator of IL‐12R expression in naïve CD4+ T cells. Nat. Immunol. 3, 549 – 557.
dc.identifier.citedreferenceNishikomori, R., Usui, T., Wu, C.Y., Morinobu, A., O’Shea, J.J., Strober, W. ( 2002 ) Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL‐12R beta 2 chain expression and signaling. J. Immunol. 169, 4388 – 4398.
dc.identifier.citedreferenceGhoreschi, K., Jesson, M.I., Li, X., Lee, J.L., Ghosh, S., Alsup, J.W., Warner, J.D., Tanaka, M., Steward‐Tharp, S.M., Gadina, M., Thomas, C.J., Minnerly, J.C., Storer, C.E., LaBranche, T.P., Radi, Z.A., Dowty, M.E., Head, R.D., Meyer, D.M., Kishore, N., O’Shea, J.J. ( 2011 ) Modulation of innate and adaptive immune responses by tofacitinib (CP‐690,550). J. Immunol. 186, 4234 – 4243.
dc.identifier.citedreferenceWei, L., Vahedi, G., Sun, H.W., Watford, W.T., Takatori, H., Ramos, H.L., Takahashi, H., Liang, J., Gutierrez‐Cruz, G., Zang, C., Peng, W., O’Shea, J.J., Kanno, Y. ( 2010 ) Discrete roles of STAT4 and STAT6 transcription factors in tuning epigenetic modifications and transcription during T helper cell differentiation. Immunity 32, 840 – 851.
dc.identifier.citedreferenceO’Sullivan, A., Chang, H.C., Yu, Q., Kaplan, M.H. ( 2004 ) STAT4 is required for interleukin‐12‐induced chromatin remodeling of the CD25 locus. J. Biol. Chem. 279, 7339 – 7345.
dc.identifier.citedreferenceElo, L.L., Järvenpää, H., Tuomela, S., Raghav, S., Ahlfors, H., Laurila, K., Gupta, B., Lund, R.J., Tahvanainen, J., Hawkins, R.D., Oresic, M., Lähdesmäki, H., Rasool, O., Rao, K.V., Aittokallio, T., Lahesmaa, R. ( 2010 ) Genome‐wide profiling of interleukin‐4 and STAT6 transcription factor regulation of human Th2 cell programming. Immunity 32, 852 – 862.
dc.identifier.citedreferenceKöck, J., Kreher, S., Lehmann, K., Riedel, R., Bardua, M., Lischke, T., Jargosch, M., Haftmann, C., Bendfeldt, H., Hatam, F., Mashreghi, M.F., Baumgrass, R., Radbruch, A., Chang, H.D. ( 2014 ) Nuclear factor of activated T cells regulates the expression of interleukin‐4 in Th2 cells in an all‐or‐none fashion. J. Biol. Chem. 289, 26752 – 26761.
dc.identifier.citedreferencePepper, M., Jenkins, M.K. ( 2011 ) Origins of CD4(+) effector and central memory T cells. Nat. Immunol. 12, 467 – 471.
dc.identifier.citedreferenceSicinska, E., Aifantis, I., Le Cam, L., Swat, W., Borowski, C., Yu, Q., Ferrando, A.A., Levin, S.D., Geng, Y., von Boehmer, H., Sicinski, P. ( 2003 ) Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 4, 451 – 461.
dc.identifier.citedreferenceYoo, J.K., Cho, J.H., Lee, S.W., Sung, Y.C. ( 2002 ) IL‐12 provides proliferation and survival signals to murine CD4+ T cells through phosphatidylinositol 3‐kinase/Akt signaling pathway. J. Immunol. 169, 3637 – 3643.
dc.identifier.citedreferenceMiyatake, S., Sakuma, M., Saito, T. ( 1997 ) Induction of interleukin‐2 unresponsiveness and down‐regulation of the JAK‐STAT system upon activation through the T cell receptor. Eur. J. Immunol. 27, 1816 – 1823.
dc.identifier.citedreferenceAjchenbaum, F., Ando, K., DeCaprio, J.A., Griffin, J.D. ( 1993 ) Independent regulation of human D‐type cyclin gene expression during G1 phase in primary human T lymphocytes. J. Biol. Chem. 268, 4113 – 4119.
dc.identifier.citedreferenceHeintzman, N.D., Hon, G.C., Hawkins, R.D., Kheradpour, P., Stark, A., Harp, L.F., Ye, Z., Lee, L.K., Stuart, R.K., Ching, C.W., Ching, K.A., Antosiewicz‐Bourget, J.E., Liu, H., Zhang, X., Green, R.D., Lobanenkov, V.V., Stewart, R., Thomson, J.A., Crawford, G.E., Kellis, M., Ren, B. ( 2009 ) Histone modifications at human enhancers reflect global cell‐type‐specific gene expression. Nature 459, 108 – 112.
dc.identifier.citedreferenceRobertson, G., Hirst, M., Bainbridge, M., Bilenky, M., Zhao, Y., Zeng, T., Euskirchen, G., Bernier, B., Varhol, R., Delaney, A., Thiessen, N., Griffith, O.L., He, A., Marra, M., Snyder, M., Jones, S. ( 2007 ) Genome‐wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat. Methods 4, 651 – 657.
dc.identifier.citedreferenceDurant, L., Watford, W.T., Ramos, H.L., Laurence, A., Vahedi, G., Wei, L., Takahashi, H., Sun, H.W., Kanno, Y., Powrie, F., O’Shea, J.J. ( 2010 ) Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 32, 605 – 615.
dc.identifier.citedreferenceSchraml, B.U., Hildner, K., Ise, W., Lee, W.L., Smith, W.A., Solomon, B., Sahota, G., Sim, J., Mukasa, R., Cemerski, S., Hatton, R.D., Stormo, G.D., Weaver, C.T., Russell, J.H., Murphy, T.L., Murphy, K.M. ( 2009 ) The AP‐1 transcription factor Batf controls T(H)17 differentiation. Nature 460, 405 – 409.
dc.identifier.citedreferenceMcMahon, K.A., Hiew, S.Y., Hadjur, S., Veiga‐Fernandes, H., Menzel, U., Price, A.J., Kioussis, D., Williams, O., Brady, H.J. ( 2007 ) Mll has a critical role in fetal and adult hematopoietic stem cell self‐renewal. Cell Stem Cell 1, 338 – 345.
dc.identifier.citedreferenceDe Bruin, A.M., Libregts, S.F., Valkhof, M., Boon, L., Touw, I.P., Nolte, M.A. ( 2012 ) IFNγ induces monopoiesis and inhibits neutrophil development during inflammation. Blood 119, 1543 – 1554.
dc.identifier.citedreferenceSavarin, C., Stohlman, S.A., Hinton, D.R., Ransohoff, R.M., Cua, D.J., Bergmann, C.C. ( 2012 ) IFN‐γ protects from lethal IL‐17 mediated viral encephalomyelitis independent of neutrophils. J. Neuroinflammation 9, 104.
dc.identifier.citedreferencePakpour, N., Zaph, C., Scott, P. ( 2008 ) The central memory CD4+ T cell population generated during Leishmania major infection requires IL‐12 to produce IFN‐gamma. J. Immunol. 180, 8299 – 8305.
dc.identifier.citedreferenceLi, Q., Eppolito, C., Odunsi, K., Shrikant, P.A. ( 2006 ) IL‐12‐programmed long‐term CD8+ T cell responses require STAT4. J. Immunol. 177, 7618 – 7625.
dc.identifier.citedreferenceFinkelman, F.D., Morris, S.C., Orekhova, T., Mori, M., Donaldson, D., Reiner, S.L., Reilly, N.L., Schopf, L., Jr Urban, J.F. ( 2000 ) Stat6 regulation of in vivo IL‐4 responses. J. Immunol. 164, 2303 – 2310.
dc.identifier.citedreferenceGood, S.R., Thieu, V.T., Mathur, A.N., Yu, Q., Stritesky, G.L., Yeh, N., O’Malley, J.T., Perumal, N.B., Kaplan, M.H. ( 2009 ) Temporal induction pattern of STAT4 target genes defines potential for Th1 lineage‐specific programming. J. Immunol. 183, 3839 – 3847.
dc.identifier.citedreferenceLund, R.J., Chen, Z., Scheinin, J., Lahesmaa, R. ( 2004 ) Early target genes of IL‐12 and STAT4 signaling in Th cells. J. Immunol. 172, 6775 – 6782.
dc.identifier.citedreferenceO’Shea, J.J., Plenge, R. ( 2012 ) JAK and STAT signaling molecules in immunoregulation and immune‐mediated disease. Immunity 36, 542 – 550.
dc.identifier.citedreferenceCalò, V., Migliavacca, M., Bazan, V., Macaluso, M., Buscemi, M., Gebbia, N., Russo, A. ( 2003 ) STAT proteins: from normal control of cellular events to tumorigenesis. J. Cell. Physiol. 197, 157 – 168.
dc.identifier.citedreferenceMartino, A., IV Holmes, J.H., Lord, J.D., Moon, J.J., Nelson, B.H. ( 2001 ) Stat5 and Sp1 regulate transcription of the cyclin D2 gene in response to IL‐2. J. Immunol. 166, 1723 – 1729.
dc.identifier.citedreferenceMatsumura, I., Kitamura, T., Wakao, H., Tanaka, H., Hashimoto, K., Albanese, C., Downward, J., Pestell, R.G., Kanakura, Y. ( 1999 ) Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine‐dependent growth of hematopoietic cells. EMBO J. 18, 1367 – 1377.
dc.identifier.citedreferenceMullen, A.C., High, F.A., Hutchins, A.S., Lee, H.W., Villarino, A.V., Livingston, D.M., Kung, A.L., Cereb, N., Yao, T.P., Yang, S.Y., Reiner, S.L. ( 2001 ) Role of T‐bet in commitment of TH1 cells before IL‐12‐dependent selection. Science 292, 1907 – 1910.
dc.identifier.citedreferenceSzabo, S.J., Kim, S.T., Costa, G.L., Zhang, X., Fathman, C.G., Glimcher, L.H. ( 2000 ) A novel transcription factor, T‐bet, directs Th1 lineage commitment. Cell 100, 655 – 669.
dc.identifier.citedreferenceQuah, B.J., Warren, H.S., Parish, C.R. ( 2007 ) Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat. Protoc. 2, 2049 – 2056.
dc.identifier.citedreferenceUsui, T., Preiss, J.C., Kanno, Y., Yao, Z.J., Bream, J.H., O’Shea, J.J., Strober, W. ( 2006 ) T‐bet regulates Th1 responses through essential effects on GATA‐3 function rather than on IFNG gene acetylation and transcription. J. Exp. Med. 203, 755 – 766.
dc.identifier.citedreferenceThieu, V.T., Yu, Q., Chang, H.C., Yeh, N., Nguyen, E.T., Sehra, S., Kaplan, M.H. ( 2008 ) Signal transducer and activator of transcription 4 is required for the transcription factor T‐bet to promote T helper 1 cell‐fate determination. Immunity 29, 679 – 690.
dc.identifier.citedreferenceKanno, Y., Vahedi, G., Hirahara, K., Singleton, K., O’Shea, J.J. ( 2012 ) Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity. Annu. Rev. Immunol. 30, 707 – 731.
dc.identifier.citedreferenceVahedi, G., Takahashi, H., Nakayamada, S., Sun, H.W., Sartorelli, V., Kanno, Y., O’Shea, J.J. ( 2012 ) STATs shape the active enhancer landscape of T cell populations. Cell 151, 981 – 993.
dc.identifier.citedreferenceAllan, R.S., Zueva, E., Cammas, F., Schreiber, H.A., Masson, V., Belz, G.T., Roche, D., Maison, C., Quivy, J.P., Almouzni, G., Amigorena, S. ( 2012 ) An epigenetic silencing pathway controlling T helper 2 cell lineage commitment. Nature 487, 249 – 253.
dc.identifier.citedreferenceMukasa, R., Balasubramani, A., Lee, Y.K., Whitley, S.K., Weaver, B.T., Shibata, Y., Crawford, G.E., Hatton, R.D., Weaver, C.T. ( 2010 ) Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 32, 616 – 627.
dc.identifier.citedreferenceAgarwal, S., Rao, A. ( 1998 ) Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9, 765 – 775.
dc.identifier.citedreferenceDomer, P.H., Fakharzadeh, S.S., Chen, C.S., Jockel, J., Johansen, L., Silverman, G.A., Kersey, J.H., Korsmeyer, S.J. ( 1993 ) Acute mixed‐lineage leukemia t(4;11)(q21;q23) generates an MLL‐AF4 fusion product. Proc. Natl. Acad. Sci. USA 90, 7884 – 7888.
dc.identifier.citedreferenceTakeda, S., Chen, D.Y., Westergard, T.D., Fisher, J.K., Rubens, J.A., Sasagawa, S., Kan, J.T., Korsmeyer, S.J., Cheng, E.H., Hsieh, J.J. ( 2006 ) Proteolysis of MLL family proteins is essential for Taspase1‐orchestrated cell cycle progression. Genes Dev. 20, 2397 – 2409.
dc.identifier.citedreferenceSchuettengruber, B., Martinez, A.M., Iovino, N., Cavalli, G. ( 2011 ) Trithorax group proteins: switching genes on and keeping them active. Nat. Rev. Mol. Cell Biol. 12, 799 – 814.
dc.identifier.citedreferenceYokoyama, A., Cleary, M.L. ( 2008 ) Menin critically links MLL proteins with LEDGF on cancer‐associated target genes. Cancer Cell 14, 36 – 46.
dc.identifier.citedreferenceHess, J.L., Yu, B.D., Li, B., Hanson, R., Korsmeyer, S.J. ( 1997 ) Defects in yolk sac hematopoiesis in Mll‐null embryos. Blood 90, 1799 – 1806.
dc.identifier.citedreferenceYagi, H., Deguchi, K., Aono, A., Tani, Y., Kishimoto, T., Komori, T. ( 1998 ) Growth disturbance in fetal liver hematopoiesis of Mll‐mutant mice. Blood 92, 108 – 117.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.